Zika Virus risk in Djibouti

Zika Virus in Djibouti: Prevention Guide Zika is a viral disease spread primarily through the bite of an infected Aedes mosquito, the same type that thrives in Djibouti's hot, arid climate with intermittent rainfall that creates breeding pools in stored water containers. Most infected people experience mild symptoms including fever, rash, joint pain, and red eyes, but infection during pregnancy can cause serious birth defects. Djibouti's risk score of 59/100 reflects moderate concern due to limited surveillance data, suitable mosquito habitat around urban areas like Djibouti City, and population movement from neighboring East African countries with active transmission. Specific local risk factors include informal water storage practices in households, standing water in construction sites, tropical temperatures supporting year-round mosquito activity, and limited public health infrastructure for rapid case detection. Protection steps: Use EPA-registered insect repellent containing DEET or picaridin on exposed skin every day, especially during dawn and dusk when Aedes mosquitoes bite most actively. Reapply after sweating or water exposure. Wear long sleeves and pants treated with permethrin insecticide. Light-colored, loose-fitting clothing reduces bites significantly, and permethrin-treated fabric provides lasting protection even after multiple washes. Eliminate standing water around your living space weekly. Empty containers, flower pots, discarded tires, and water storage vessels. Cover any water storage containers tightly since Aedes mosquitoes breed in small amounts of clean water. Use air conditioning and window screens when available. Sleep under insecticide-treated bed nets, particularly important in areas without screened housing. Nets should have no holes and be tucked securely under mattresses. Pregnant women or those planning pregnancy should avoid non-essential travel to Djibouti. If travel is necessary, consult a travel medicine specialist at least four weeks before departure for additional guidance on testing and monitoring.